Clinical Trials Logo

Clinical Trial Summary

The primary object of this study is evaluating the efficacy of ZX-7101A tablets versus placebo in the treatment of uncomplicated simple influenza in adolescents. The seongdary object is evaluating the safety of ZX-7101A tablet in the treatment of uncomplicated simple influenza in adolescents.


Clinical Trial Description

In this study, adolescents aged 12 and < 18 with uncomplicated influenza are selected as subjects. Typical systemic and/or respiratory influenza symptoms were required, and the time interval between the first onset of influenza symptoms and random enrollment was less than 48 hours. This study is divided into screening/treatment period (D1) and observation period (about 2 weeks). You will be eligible before starting study therapy on day 1 (D1). Participants were randomly assigned 1:1 to ZX-7101A group (dose 40 mg, administration once) or placebo group (dose 1 placebo tablet, administration once), with 180 participants planned to be included in each group, for a total of about 360 participants. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06099873
Study type Interventional
Source Nanjing Zenshine Pharmaceuticals
Contact Zhang Wenhong, Doctor
Phone 13816357098
Email zhangwenhong202208@126.com
Status Not yet recruiting
Phase Phase 3
Start date October 25, 2023
Completion date November 15, 2024

See also
  Status Clinical Trial Phase
Terminated NCT04898023 - Zinc and Green Tea Extract for Community Respiratory Viral Infections Phase 2
Withdrawn NCT04842331 - PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) Phase 2/Phase 3
Completed NCT02260596 - Respiratory Viral Infections in Pediatric Transplantation N/A
Completed NCT04898140 - The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents
Completed NCT04611061 - Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers
Not yet recruiting NCT05618483 - Xylitol Based Nasal Spray for COVID-19 Treatment N/A
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Terminated NCT04141917 - Test-and-treat for Influenza in Homeless Shelters Phase 4
Recruiting NCT06017310 - Respiferon Project
Enrolling by invitation NCT06188988 - Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
Completed NCT04141930 - Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle Phase 4
Completed NCT05846360 - The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer
Completed NCT04532411 - COVID-19 Testing Sample Acquisition Throughput and Efficiency
Active, not recruiting NCT04258059 - Wells and Enteric Disease Transmission Trial (WET - Trial) N/A
Active, not recruiting NCT04482673 - Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection Phase 4
Not yet recruiting NCT05946538 - Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics N/A
Recruiting NCT05092607 - Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19 N/A
Recruiting NCT05913700 - Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Recruiting NCT04826991 - Wells and Enteric Disease Transmission N/A
Terminated NCT04664075 - Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)